Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 2c

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q1 EPS of ($0.53), $0.02 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $379 thousand versus the consensus estimate of $360 thousand.

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• NVE Corporation names new CEO and expands board to seven members
• Worried the AI trade has gone too far? Evercore likes these 4 stocks